A specific anti-cyclin D1 intrabody represses breast cancer cell proliferation by interrupting the cyclin D1–CDK4 interactionJialiang Zhao, Guiying Li, Tong Xiao et al.|Breast Cancer Research and Treatment|2023Cited by 5